Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Neuroprotection in Brain Surgery
NCT02878707Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in brain tumor and cerebrovascular disease (CVD), sponsored by National Taiwan University Hospital. Primary endpoint: Number of participants with postoperative neurological complications at 10 days. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
brain tumorcerebrovascular disease (CVD)
Beyond the preview
Go deeper on NCT02878707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878707.